WE CHANGE THE WORLD
ONE NEURON AT A TIME
Nomadogen is a medical biotechnology company founded by four graduate student members of the award-winning University of Lethbridge 2014 International Genetically Engineered Machines (iGEM) team.
Nomadogen's patented technology is a combination genetic and cellular therapy dubbed "Nomadocytes", which utilizes patient-derived cells to non-invasively deliver therapeutic molecules to brain cells affected by stroke, traumatic brain injury, and neurodegenerative disease. Nomadocytes are currently in preclinical trials.